Beta
(1/3; 1/6) Glucans
Beta glucans are polysaccharides (sugar molecules) found bound together as
a sugar/protein complex. The richest concentrated source of beta glucan is
baker's yeast cell walls, but it is also present in lesser amounts in barley,
oats, and some seaweeds, mushrooms, and other plants. Beta glucan extract taken
from these natural materials does not contain the protein part of the complex,
so it is not allergy inducing. Hundreds of scientific reports attest to beta
glucans ability to enhance the immune system. Having demonstrated widespread
immune enhancing effects, beta glucan has been used to improve conditions ranging
from gingivitis and periodontitis to cancer.
Glucans appear to stimulate (irritate) the large white blood cells called macrophages
into action. These cells are a primary defense system for our bodies, identifying
abnormal conditions and activating the appropriate therapeutic response. They
literally devour bacteria, foreign cells, dead and dying cells, mutated cells,
cancerous cells, and other negative invaders. Beta glucan’s stimulation
of macrophage cells produces a cascade of immune events, boosting immune response,
stimulating the production of immune cells and improving host resistance.
History of Beta Glucans
A substance called Zymosan was discovered in the late 1940’s. Research
showed that this product had several immune activating properties. These properties
were researched one by one until the 1960’s when Nicholas DiLuzio of
Tulane University began experimenting with Beta 1,3-D Glucan. The glucan was
discovered to be responsible for the immune activating response. Then, Beta
1,3-D glucan was introduced to human subjects in the 1970’s.
Another function of glucan is its ability to act as a strong antioxidant or
free radical scavenger. I have a very large clientele of mercury toxic patients
and work closely with amalgam-free dentists. Mercury and other heavy metals
are free radical producers, initiating a cascade of tissue destruction and
impaired function. In retraining the patient’s detoxification mechanisms,
one component which has to be addressed is liver phase I detoxification. This
process needs vast amounts of antioxidant and glucans can help to provide that,
along with the other factors I have the patients take in their protocol.
Glucans can also protect you from various forms of radiation. It scavenges
debris and cellular breakdown caused by radiation. Some forms of radiation
that glucan can protect you from is airline travel, x-rays, mammograms, high
tension power lines, proximity to nuclear facilities, computer terminals and
UV rays from the sun.
Beta 1,3-D glucan can also regenerate and repair tissue, thus, speeding up
the recovery of damaged tissue as well.
Glucan aids in the lowering of LDL (bad) cholesterol and enhances cholesterol
lowering regimes.
Beta1,3-D glucan helps other substances such as antibiotics, antifungals and
antiparasitics to work better in the body. However, the most important effect
is has on the body is the anti-neoplastic (anti-tumor) effect. With glucan
in the system, the macrophages are far more efficient at recognizing and destroying
mutated cells.
Beta-Glucan Research Update
Enhancement of radioprotection and anti-tumor immunity by yeast-derived beta-glucan
in mice.
J Med Food. 2005 Summer;8(2):154-8.
Department of Radiological Technology, Suzuka University of Medical Science,
Suzuka, Japan.
Intraperitoneal injection of beta glucan was shown to greatly delay mortality
in mice exposed to whole-body X-ray radiation and tumor growth in tumor-bearing
mice. Since the leukocyte and lymphocyte numbers were increased by a single
dose of beta-glucan, the radioprotective effect of beta-glucan is probably
mediated, at least in part, by a hemopoietic action in irradiated mice. In
addition, both natural killer (NK) and lymphokine-activated killer (LAK) activities
were significantly increased by repeated doses of beta-glucan. Augmented immunological
activity as seen in increased NK and LAK activity by beta glucan seems to play
a role in preventing secondary infections associated with irradiation, and
probably contributes to the attenuated tumor growth in tumor-bearing mice through
enhanced anti-tumor immunity. These results suggest that beta glucan may be
a promising adjunct treatment for cancer patients receiving radiotherapy.
Effects of oat beta-glucan on innate immunity and infection after exercise
stress.
Med Sci Sports Exerc. 2004 Aug;36(8):1321-7.
To test the effects of oat beta glucan on respiratory infection, macrophage
antiviral resistance, and NK cytotoxicity. Mice were randomly assigned to one
of four groups: Ex-H2O, Ex- beta glucan, Con-H2O, or Con beta glucan. Beta
glucan was fed in the drinking water for 10 d before intranasal inoculation
of HSV-1 or sacrifice. Exercise consisted of treadmill running to volitional
fatigue for three consecutive days. Fifteen minutes after the last bout of
exercise or rest, mice were intranasally inoculated with a standardized dose
of HSV-1. Mice were monitored twice daily for morbidity and mortality. RESULTS:
Exercise stress was associated with a 28% increase in morbidity and 18% increase
in mortality. Ingestion of beta glucan before infection prevented this increase
in morbidity and mortality. Exercise stress was associated with a decrease
in macrophage antiviral resistance, which was blocked by ingestion of beta
glucan. There were no effects of exercise or beta glucan on NK cytotoxicity.
CONCLUSION: These data suggest that daily ingestion of beta glucan may offset
the increased risk of upper respiratory infection associated with exercise
stress, which may be mediated, at least in part, by an increase in macrophage
antiviral resistance.
Reduced and High Molecular Weight Barley {beta}-Glucans Decrease Plasma Total
and Non-HDL-Cholesterol in Hypercholesterolemic Syrian Golden Hamsters.
J Nutr. 2004 Oct;134(10):2617-2622.
Department of Health and Clinical Sciences, University of Massachusetts-Lowell,
Lowell, MA
Consumption of concentrated barley beta-glucan lowers plasma cholesterol because
of its soluble dietary fiber nature. The role of molecular weight (MW) in lowering
serum cholesterol is not well established. Prior studies showed that enzymatic
degradation of beta-glucan eliminates the cholesterol-lowering activity; however,
these studies did not evaluate the MW of the beta-glucan. The current study was
conducted to evaluate whether barley beta-glucan concentrates, partially hydrolyzed
to reduce MW, possess cholesterol-lowering and antiatherogenic activities. The
reduced MW fraction was compared with a high MW beta-glucan concentrate from
the same barley flour. Concentrated beta-glucan preparations were evaluated in
Syrian Golden hamsters fed a hypercholesterolemic diet (HCD) with cholesterol,
hydrogenated coconut oil, and cellulose. After 2 wk, hamsters were fed HCD or
diets that contained high or reduced MW beta-glucan at the expense of cellulose.
Decreases in plasma total cholesterol (TC) and non-HDL-cholesterol (non-HDL-C)
concentrations occurred in the hamsters fed reduced MW and high MW beta-glucan
diets. Plasma HDL-C concentrations did not differ. HCD-fed hamsters had higher
plasma triglyceride concentrations. Liver TC, free cholesterol, and cholesterol
ester concentrations did not differ. Aortic cholesterol ester concentrations
were lower in the reduced MW beta-glucan-fed hamsters. Consumption of either
high or reduced MW beta-glucan increased concentrations of fecal total neutral
sterols and coprostanol, a cholesterol derivative. Fecal excretion of cholesterol
was greater than in HCD-fed hamsters only in those fed the reduced MW beta-glucan.
Study results demonstrate that the cholesterol-lowering activity of barley beta-glucan
may occur at both lower and higher MW.
Beta-glucan, extracted from oat, enhances disease resistance against bacterial
and parasitic infections.
FEMS Immunol Med Microbiol. 2003 Jan 21;35(1):67-75.
The effect of beta-glucan, extracted from oats, on the enhancement of resistance
to infections caused by Staphylococcus aureus and Eimeria vermiformis was studied
in mice. In vitro study using macrophages isolated from the peritoneal cavity
showed that beta-glucan treatment significantly enhanced phagocytic activity.
In vivo study further demonstrated that beta-glucan treatment induced a significant
protection against the challenge with S. aureus in mice. Fecal oocyst shedding
in the C57BL/6 mice infected with E. vermiformis was diminished by beta-glucan
treatment by 39% in intraperitoneal and 28% in intragastric group compared to
non-treated control. Patency period was shorter and antigen (sporozoites and
merozoites) specific antibodies were significantly higher in beta-glucan-treated
group compared to non-treated control group. There were an increasing number
of splenic IFN-gamma-secreting cells in glucan-treated group via intraperitoneal
route, which might be responsible for the enhancement of the disease resistance.
In conclusion, the oral or parenteral oat beta-glucan treatment enhanced the
resistance to S. aureus or E. vermiformis infection in the mice.
Sweeteners and beta-glucans improve metabolic and anthropometrics variables in
well controlled type 2 diabetic patients.
Am J Ther. 2003 Nov-Dec;10(6):438-43.
To compare metabolic and anthropometric improvements elicited by a diet based
on the American Diabetic Association's nutrition recommendations with a modified,
low-energy diet incorporating fat replacers and non-sucrose sweeteners. DESIGN:
A total of 16 male, well controlled type 2 diabetes patients were divided into
two groups of eight; one group received the diet based on the American Diabetic
Association's nutrition recommendations, and the other was fed a modified, low-calorie
diet containing a fat replacer (beta-glucans derived from oats) and the sweeteners,
sucralose and fructose. Both groups were maintained on their respective diets
for 4 weeks. All patients performed daily aerobic exercise consisting of walking
for 60 minutes. Body weight, body mass index, basal glycemia, hemoglobin HbA1C,
and lipid profile were determined in each patient before starting the diets and
after 4 weeks of dietary intervention. RESULTS: Both diets produced significant
improvements in weight, body mass index, lipid profile, basal glucose, and HbA1C.
However, the beta glucan diet was superior to the American Diabetic Association's
diet in improving metabolic and anthropometric profile: greater increase in HDL
cholesterol and larger decreases in HbA1C, weight, and body mass index. CONCLUSIONS:
A diet incorporating a beta-glucans and non-sucrose sweeteners produced a greater
improvement in metabolic and anthropometric variables in well controlled type
2 diabetic patients when compared with a diet based on American Diabetic Association's
nutrition recommendations.
Beta 1,3-D glucan has been extensively researched and documented by some of the
most prestigious universities in the world. To quote some of the involved scientists:
M. L. Patchen, PhD
Department of Experimental
Hematology and Radiation Sciences
Armed Forces Radiobiology Institute
" Glucan has been shown to enhance macrophage production dramatically,
and to increase nonspecific host resistance to a variety of bacterial, fungal
and parasitic infections."
William Browder M.D.
Department of Surgery
Tulane University School of Medicine
" Beta 1,3-D glucan is a potent macrophage stimulant and is
beneficial
in the therapy
of experimental bacterial, viral and fungal diseases."
Joyce K. Czop, M.D.
Department of Rheumatology and Immunology
Harvard Medical School
“ A cascade of interactions and reactions initiated by the
macrophage regulatory factors can be envisioned to occur and to eventuate in
conversion
of the glucan
treated host to an arsenal of defense.”
P. Mansell, M.D.
McGill University Cancer
Research Center
Victoria Hospital, Montreal, Canada
" Glucan was found to be an effective drug in inducing macrophage-mediated
destruction
in malignant lesions in animals and humans."
Dr. Peter Mansell conducted a study where beta glucan was injected into subcutaneous
(under the skin) nodules of malignant melanoma. Biopsies of these sites revealed
that no evidence of melanoma could be found, only a collection of activated macrophages.
DiLuzzio N.R. "Immuneo-pharmacology of glucan: a broad spectrum enhancer
of host defense mechanisms," Trends in Pharmacol. SCI, 4:344-437.1983. Dept.
of Physiology, Tulane U. New Orleans, LA. Quote: "The broad spectrum of
immunopharmacological activities of glucan includes not only the modification
of certain bacterial, fungal, viral and parasitic infections, but also the inhibition
of tumor growth."
Di Luzzio N.R. Williams D.L., et al. "Comparative tumor inhibitory and anti-bacterial
activity of soluble and particulate glucan," Int. J Cancer. 24(6):773-779.
Dec 1979. Quote: " These studies demonstrate that a soluble glucan preparation
exhibits significant anti-tumor and anti-staphylococcal activity."
Other research studies have shown the positive effects of beta glucan on an array
of conditions such as malignant ulcers of the chest following a mastectomy, HIV
infections, severe trauma complications, and radiation exposure. Beta glucan
has also been shown to enhance the effectiveness of antibiotics and antiviral
medications.
There are researchers who believe that Beta 1,3-D glucan is the only true defense
against aging.
The presence of Beta potentiates the receptors on the surface of the macrophage.
Only the presence of non-self (virus, bacteria, fungi, cancer, parasites, etc.)
causes the macrophage to become stimulated. Beta alone does not stimulate.
Beta-1, 3-D glucan does not create a danger in over expansion of the immune system.
Considerable peer reviewed data indicates just the opposite.
There are no adverse effects known when Beta-1, 3-D glucan is taken in conjunction
with pharmacological drugs. Beta-1, 3-D glucan enhances the effect of many anti-infective
drugs, cholesterol reducing drugs and chemotherapeutic agents.
People often wonder why this product has not been available before. For nearly
three decades, Beta-1, 3-D glucan has been available to laboratories and medical
schools. However, to purchase 1 (one) 100-mg sample of Beta-1, 3-D glucan, cost
was close to $200.00! This made it highly prohibitive from a commercial standpoint.
Finally that has changed and we are able to bring this highly effective, highly
researched product to you.
Frequently Asked Questions About Beta Glucan 1, 3
D Glucan
What is beta 1, 3 d glucan?
Beta 1, 3 d glucan is the sole active ingredient in beta glucan. It is derived
from the cell walls of baker's yeast (saccharomyces cerevisiae). Beta glucan
is known by immunologists for its amazing immune enhancing properties.
How does beta 1, 3 d glucan work?
Beta Glucan stimulates the macrophage, a white blood cell that is responsible
for a multitude of actions which protect and enhance the immune system, and provide
optimum resistance to any possible health assailants. Macrophage cells
are one of the principal cell types involved in natural immunity. They swallow
up foreign particles and destroy them. Macrophages produce chemicals that signal
other immune cells to move to the site of infection and produce such effects
as fever. Macrophages also produce growth factors for cells that repair
injured tissues.
All immune functions are improved, including phagocytosis (ability to engulf
foreign cells and particles) release of certain cytokines (intercellular hormones)
IL-1, IL-6, GM-CSF, interferons, and the processing of antigens. Macrophages
are involved in everyday detoxifying processes, intestinal flora maintenance,
anti-infective and anti-tumor protection and maintenance of overall health integrity.
Beta Glucan taken orally differs from other food substances. This type of glucan
is acid resistant so it passes through the stomach virtually unchanged. Macrophages
in the mucous lining of the intestinal wall pick up the beta glucan particles
through beta glucan receptors. Immediate activation of these cells follows, and
they are later able to travel back to the local lymph nodes (Peyer’s Patch)
as part of their natural antigen-presenting function, to release cytokines and
induce systematic immune activation.
I am allergic to yeast . . . will taking beta 1, 3 d glucan
cause
an allergic
reaction?
No. Yeast proteins cause your allergic reactions to yeast products. Although
beta glucan are derived from baker's yeast (Saccharomyces ceravisiae), beta 1,
3 d glucan is a pure isolate and does not contain enough yeast proteins to cause
an allergic reaction.
I am concerned about over-stimulating my immune system . . . is this a possibility
with beta 1, 3 d glucan?
No . . . only the presence of non-self (virus, bacteria, fungi cancer, parasites,
etc.) cause the macrophage to become alert.
Will beta 1, 3 d glucan cause or increase an autoimmune condition?
Beta 1, 3 d glucan does not pose a danger for people with autoimmune problems.
Considerable peer reviewed data indicates that it actually helps people's immune
systems to lessen the effects of autoimmune disorders such as diabetes, arthritis,
psoriasis, etc.
Is beta 1, 3 d glucan safe . . . can I suffer any adverse reactions?
Baker’s yeast extracts have been given a G.R.A.S. Rating (Generally Regarded
As Safe) Rating by the FDA. To achieve this rating a substance must have
no known adversity or toxicity.
Who should take beta 1, 3 d glucan?
- People
with impaired immunity.
- People
who are susceptible to allergies, autoimmune disease, infectious
disease, slow and incomplete healing and cancer.
- People
wishing to slow the aging process.
- People
undergoing radiation or chemotherapy.
- People
over 40 whose immune systems begin to slow through the
aging process and geriatric patients.
- People
who are exposed to radiation from external sources such
as UV or electromagnetic fields.
- People
with poor nutrition or who consume food preservatives.
- People
under physical or emotional stress.
- Athletes
and those who work out extensively.
- People
with high risk of cardiovascular disease.
- Animals!
To help them overcome illness, stay healthy and live longer.
- Basically
any person who wants to protect their immune system.
|
Are there any drug reactions that occur when taken
with beta 1, 3 d glucan?
There are no adverse effects known when beta 1, 3 d glucan is taken in conjunction
with pharmacological drugs. Beta 1, 3 d glucan enhances the effect of many
anti-infective drugs, cholesterol reducing drugs and chemotherapeutic agents. Please
advise your health practitioner of this benefit so that your drugs can be reduced
as needed.
If beta 1, 3 d glucan is so wonderful . . . why haven't I heard about it before?
For nearly three decades, beta 1, 3 d glucan was available only in laboratories
and medical schools. To purchase 1 (one) 100-mg sample of beta 1, 3 d glucan,
cost was close to $200.00! Unfortunately, this made it very unaffordable
to the general public.
Are glucan from barley, oats, or other grains as effective as the beta glucan
derived from bakers yeast?
They have been shown to be ineffective as an immune modulator. Only beta
1, 3 d glucan from the cell wall of baker's yeast has been shown to have a
potent effect on the immune system in an economical manner.
Beta Glucan and the Immune System
The immune system is very complex and nutritionally it is a nightmare to understand.
Vitamins and minerals are important components of many of the chemical messengers
produced by immune cells. Basically there are two parts of the immune system
one is called the humoral immune system the other is called the cellular immune
system. The humoral part is responsible for the production of antibodies
and memory (acquired immunity), and the cellular part (natural immunity) protects
without prior exposure to foreign substances. By convention, immunology is the
study of acquired immunity and "immune response" refers to responses
that are induced by antigens or foreign substances.
The other side, the natural or innate system includes, skin, mucous membranes,
complement, phagocytes, and macrophage-derived cytokines (chemicals from cells).
The Phagocytes make up the second major cell population of the immune system. The
macrophage is a principle form of phagocyte. In the 1970's it was observed that
macrophages infiltrate tumors and speculated that this infiltration was the first
line of defense against metastatic spread (Birbeck and Carter 1972, VanLoveren
and DenOtter 1973, Mansell et al. 1975). Tumor associated macrophages have been
identified in several species and there is little doubt that the macrophage plays
an important role in the host-tumor relationship. Since macrophages infiltrate
tumors it is likely that they are the first line of defense against the spread
of tumors. These cells take up other particles and foreign invaders such as microbes
and represent the clearest example of cells that are critical for natural immunity
(they also play a role in acquired immunity). Macrophages are one of the principal
cell types involved in natural immunity, they swallow-up foreign particles and
destroy or process them. These cells release enzymes, and other substances
that kill microbes, and tumor cells and control the spread of infection. Often
the release of these chemicals can damage normal tissues in the immediate area,
leading to inflammation. Macrophages produce chemicals that signal other
immune cells to the site of infection and produce such effects as fever. Macrophages
also produce growth factors for cells that repair injured tissues. These cells
do play various important roles in the progression of acquired immune responses
as well. However, explanation of acquired antibody responses is also beyond
the scope of this writing, here we will focus on cellular or natural immunity,
and
the macrophage.
Bacteria are capable of growing outside of cells, in circulation, in connective
tissue, and in spaces and airways in the human body. These microorganisms
can cause disease in two basic ways. First, they induce inflammation that
damages surrounding tissue. Second, bacteria produce toxins with differing
effects. Such toxins may be endotoxins, which are parts of the broken bacterial
cell wall, or exotoxins, which the bacteria make and release. One type of endotoxin,
a polysaccharide (similar to beta glucan) called lipopolysaccharide or LPS is
a potent stimulator of immune cells. Immune cells respond to LPS in an effort
to eliminate the bacteria producing it. Because bacteria, and tumor cells are
rapidly killed by macrophages and the resistance of bacterial and tumor
cells to phagocytosis is an important factor in how successful they are. Both
cell types succeed by multiplying rapidly and overwhelming the immune system.
For bacteria, toxins such as LPS are released as old bacteria die, and these
stimulate the production of chemicals by macrophages that end up destroying
the bacteria that released the toxin.
Both nutrient and non-nutrient compounds that have been shown to affect the
immune system. Beta glucan polysaccharides are capable of stimulating macrophages
(and
other immune cells) and are capable of acting as dietary immunological response
modifiers. Beta glucan carries a rating from the FDA, Generally Regarded As
Safe (GRAS), which means that there is no known toxicity for an oral dose of
the purified
form. There is much evidence in scientific literature over the past 70
years indicating that beta glucan stimulates the macrophage to engulf foreign
particles more efficiently, fight the growth and spread of tumors and is effective
as a preventive treatment in promoting health.
Anthrax Research Presented at American Chemical Society National Meeting
BOSTON, August. 22, 2002 — A compound from baker’s yeast (BETA
GLUCAN), used to make bread rise, may one day help protect people against deadly
anthrax
infections, according to researchers.
In laboratory tests, the compound, called WGP Beta Glucan, significantly increased
the survival rate of mice infected with lethal anthrax spores. Researchers
believe the compound can be developed into a potent drug that has a similar
effect on
humans. Their findings were presented today at the 224th national meeting of
the American Chemical Society, the world’s largest scientific society.
WGP Beta Glucan is a patented form of beta 1,3-glucan, a polysaccharide derived
from the cell wall of baker’s yeast and other natural sources. Beta 1,3-glucan’s
potential health benefits, particularly its immune-enhancing properties, have
been the subject of numerous scientific studies.
The current study represents the first demonstration that a specific form of
beta 1,3-glucan can enhance the immune system’s ability to kill anthrax
spores, and that it can do so orally, says Gary R. Ostroff, Ph.D., vice president
of research and development at Biopolymer Engineering Inc., in Eagan, Minn.
The study involved 80 mice, all of which were infected with a lethal dose of
deadly anthrax spores. Of the 20 that received a placebo treatment, 30 to 50
percent survived. Of the 60 mice given beta glucan, 75 to 100 percent survived,
the researcher said.
Although the mechanism of the glucan compound is not completely understood, it
appears to work by binding to and strengthening macrophages, immune cells that
are the first line of defense against bacterial infection. As a result, the cells
fight harder against infection. In the case of anthrax, the fortified macrophage
cells appear to kill the bacterial spores before they have a chance to germinate
and spawn the deadly toxins that can quickly overwhelm a less-protected immune
system, the researcher explained.
Studies are planned to determine the level of immune system protection that glucan
offers specifically against anthrax spores, Ostroff said. The compound could
potentially be developed into a drug that would work synergistically with existing
anthrax therapies, including vaccines and antibiotics and antibodies to the anthrax
toxin, he added.
Funding for this study was provided by Biopolymer Engineering Inc.; the Defense
Research Establishment Suffield, Alberta, Canada; and Biophage Pharma Inc., Montreal,
Canada.
The paper on this research, CARB 99, will be presented at 1:20 p.m., Thursday,
Aug. 22, at Sheraton Boston, Republic B, as part of the topic “General
Contributed Papers: Biochemistry of Carbohydrates.”
— Mark T. Sampson
— Senior Science
Writer
— American Chemical
Society
— Office of Communications
— 1155 Sixteenth
Street, N.W.
— Washington, D.C.
20036
— Phone: (202) 872-4097
— Fax: (202) 776-8235
— e-mail: m_sampson@acs.org
Beta Glucan and Radiation
Radiation therapy and chemotherapy in the treatment of cancer often lead to myelosuppression,
a compromised ability to create new blood cells. In this suppressed immune
state, patients are more susceptible to infections and other pathogenic challenges.
Research by the U.S. Armed Forces Radiobiology Research Institute and others
have found that systemic beta glucan reduces the time of recovery from radiation-induced
myelosuppression, synergizing with endogenous cytokine and growth factor stimulation
of hematopoeisis (formation of blood cells) in the bone marrow. In a preclinical
study, white blood cell counts recovered 4 days faster than control animals following
a sublethal dose of radiation (Figure 1). The importance of this faster recovery
is evidenced by an increase in survival from 0% in control animals to 50% in
beta glucan treated animals following a lethal dose of radiation (Figure 2).
Furthermore, beta glucan's unique mechanism action enhances the microbial killing
activities of the macrophages and neutrophils. This important benefit provides
the body with additional protection as it struggles to restore its immune system
defenses. There is significant animal research demonstrating beta glucan's ability
to enhance the innate immune response against bacterial and viral infections,
and also demonstrating a synergistic effect when used in conjunction with antibiotics
(Figure 3).
(Figure
1)
 |
(Figure
2)
 |
(Figure 3)
 |
> Return to Ingredient List
> Return Home
|